SDC2 and hemophilia A: The results showed two drugs targeting SDC2: Palifermin, which is used for the prevention and treatment of oral mucositis, and Efanesoctocog alfa, which is indicated for the treatment of hemophilia A. However, to date, no drugs targeting SDC2 for the treatment of HF have been developed.